Annual EBITDA
-$9.29 M
+$789.00 K+7.83%
December 1, 2023
Summary
- As of February 7, 2025, ARTL annual EBITDA is -$9.29 million, with the most recent change of +$789.00 thousand (+7.83%) on December 1, 2023.
- During the last 3 years, ARTL annual EBITDA has fallen by -$1.85 million (-24.90%).
- ARTL annual EBITDA is now -61011.84% below its all-time high of -$15.20 thousand, reached on August 31, 2015.
Performance
ARTL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.20 M
+$1.32 M+52.43%
September 1, 2024
Summary
- As of February 7, 2025, ARTL quarterly EBITDA is -$1.20 million, with the most recent change of +$1.32 million (+52.43%) on September 1, 2024.
- Over the past year, ARTL quarterly EBITDA has increased by +$1.39 million (+53.84%).
- ARTL quarterly EBITDA is now -238900.00% below its all-time high of -$500.00, reached on August 31, 2014.
Performance
ARTL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$8.89 M
+$1.42 M+13.76%
September 1, 2024
Summary
- As of February 7, 2025, ARTL TTM EBITDA is -$8.89 million, with the most recent change of +$1.42 million (+13.76%) on September 1, 2024.
- Over the past year, ARTL TTM EBITDA has increased by +$691.00 thousand (+7.21%).
- ARTL TTM EBITDA is now -134672.73% below its all-time high of -$6600.00, reached on February 28, 2014.
Performance
ARTL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARTL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | +53.8% | +7.2% |
| 3 y3 years | -24.9% | +36.5% | -19.6% |
| 5 y5 years | -189.5% | -25.4% | -85.9% |
ARTL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -130.2% | +7.8% | at high | +64.2% | -3.0% | +14.7% |
| 5 y | 5-year | -189.5% | +7.8% | -25.6% | +64.2% | -123.0% | +14.7% |
| alltime | all time | <-9999.0% | +7.8% | <-9999.0% | +64.2% | <-9999.0% | +14.7% |
Artelo Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.20 M(-52.4%) | -$8.89 M(-13.8%) |
| Jun 2024 | - | -$2.51 M(-3.0%) | -$10.31 M(+7.6%) |
| Mar 2024 | - | -$2.59 M(-0.4%) | -$9.59 M(+3.2%) |
| Dec 2023 | -$9.29 M(-7.8%) | -$2.60 M(-0.6%) | -$9.29 M(-7.4%) |
| Sep 2023 | - | -$2.61 M(+46.5%) | -$10.03 M(+3.0%) |
| Jun 2023 | - | -$1.78 M(-22.2%) | -$9.74 M(-6.6%) |
| Mar 2023 | - | -$2.29 M(-31.4%) | -$10.43 M(+3.4%) |
| Dec 2022 | -$10.08 M(+149.8%) | -$3.34 M(+43.6%) | -$10.08 M(+8.5%) |
| Sep 2022 | - | -$2.33 M(-5.9%) | -$9.29 M(+5.0%) |
| Jun 2022 | - | -$2.47 M(+27.0%) | -$8.85 M(+2.5%) |
| Mar 2022 | - | -$1.95 M(-23.7%) | -$8.63 M(+0.9%) |
| Dec 2021 | -$4.04 M(-45.7%) | - | - |
| Nov 2021 | - | -$2.55 M(+35.5%) | -$8.55 M(+15.0%) |
| Aug 2021 | -$7.44 M(+58.7%) | -$1.88 M(-16.4%) | -$7.44 M(+13.0%) |
| May 2021 | - | -$2.25 M(+20.6%) | -$6.58 M(+24.6%) |
| Feb 2021 | - | -$1.87 M(+30.0%) | -$5.28 M(+10.4%) |
| Nov 2020 | - | -$1.44 M(+39.7%) | -$4.79 M(+2.1%) |
| Aug 2020 | -$4.69 M(+46.0%) | -$1.03 M(+8.0%) | -$4.69 M(+1.6%) |
| May 2020 | - | -$951.30 K(-30.6%) | -$4.61 M(+0.2%) |
| Feb 2020 | - | -$1.37 M(+2.6%) | -$4.60 M(+15.4%) |
| Nov 2019 | - | -$1.34 M(+40.2%) | -$3.99 M(+24.3%) |
| Aug 2019 | -$3.21 M | -$953.30 K(+1.3%) | -$3.21 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2019 | - | -$941.00 K(+24.2%) | -$2.95 M(+14.1%) |
| Feb 2019 | - | -$757.80 K(+36.1%) | -$2.58 M(-1.5%) |
| Nov 2018 | - | -$556.80 K(-19.3%) | -$2.62 M(+11.9%) |
| Aug 2018 | -$2.34 M(+906.5%) | -$690.00 K(+19.4%) | -$2.34 M(+32.5%) |
| May 2018 | - | -$577.80 K(-27.6%) | -$1.77 M(+37.5%) |
| Feb 2018 | - | -$798.40 K(+188.2%) | -$1.29 M(+157.2%) |
| Nov 2017 | - | -$277.00 K(+139.6%) | -$500.30 K(+114.9%) |
| Aug 2017 | -$232.80 K(+683.8%) | -$115.60 K(+20.8%) | -$232.80 K(+91.6%) |
| May 2017 | - | -$95.70 K(+697.5%) | -$121.50 K(+294.5%) |
| Feb 2017 | - | -$12.00 K(+26.3%) | -$30.80 K(+28.9%) |
| Nov 2016 | - | -$9500.00(+120.9%) | -$23.90 K(-19.3%) |
| Aug 2016 | -$29.70 K(+95.4%) | -$4300.00(-14.0%) | -$29.60 K(-1.0%) |
| May 2016 | - | -$5000.00(-2.0%) | -$29.90 K(+9.1%) |
| Feb 2016 | - | -$5100.00(-66.4%) | -$27.40 K(-3.9%) |
| Nov 2015 | - | -$15.20 K(+230.4%) | -$28.50 K(+86.3%) |
| Aug 2015 | -$15.20 K(-0.7%) | -$4600.00(+84.0%) | -$15.30 K(+36.6%) |
| May 2015 | - | -$2500.00(-59.7%) | -$11.20 K(-33.3%) |
| Feb 2015 | - | -$6200.00(+210.0%) | -$16.80 K(-2.3%) |
| Nov 2014 | - | -$2000.00(+300.0%) | -$17.20 K(+13.2%) |
| Aug 2014 | -$15.30 K | -$500.00(-93.8%) | -$15.20 K(+3.4%) |
| May 2014 | - | -$8100.00(+22.7%) | -$14.70 K(+122.7%) |
| Feb 2014 | - | -$6600.00 | -$6600.00 |
FAQ
- What is Artelo Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Artelo Biosciences?
- What is Artelo Biosciences annual EBITDA year-on-year change?
- What is Artelo Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Artelo Biosciences?
- What is Artelo Biosciences quarterly EBITDA year-on-year change?
- What is Artelo Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Artelo Biosciences?
- What is Artelo Biosciences TTM EBITDA year-on-year change?
What is Artelo Biosciences annual EBITDA?
The current annual EBITDA of ARTL is -$9.29 M
What is the all time high annual EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high annual EBITDA is -$15.20 K
What is Artelo Biosciences annual EBITDA year-on-year change?
Over the past year, ARTL annual EBITDA has changed by +$789.00 K (+7.83%)
What is Artelo Biosciences quarterly EBITDA?
The current quarterly EBITDA of ARTL is -$1.20 M
What is the all time high quarterly EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high quarterly EBITDA is -$500.00
What is Artelo Biosciences quarterly EBITDA year-on-year change?
Over the past year, ARTL quarterly EBITDA has changed by +$1.39 M (+53.84%)
What is Artelo Biosciences TTM EBITDA?
The current TTM EBITDA of ARTL is -$8.89 M
What is the all time high TTM EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high TTM EBITDA is -$6600.00
What is Artelo Biosciences TTM EBITDA year-on-year change?
Over the past year, ARTL TTM EBITDA has changed by +$691.00 K (+7.21%)